← FDA Drug Approvals (Drugs@FDA)
CISATRACURIUM BESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2017-06-16
Drug application
- FDA Application #
ANDA205873- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CISATRACURIUM BESYLATE
- Generic name
- Cisatracurium Besylate
- Active ingredients
- CISATRACURIUM BESYLATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- ACCORD HLTHCARE
- First approval
- 2017-06-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown